Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does severe renal insufficiency increase the risk of bleeding after administration of low-molecular-weight heparin?

Nature Clinical Practice Nephrology volume 2, pages 616–617 (2006)Cite this article

boxed-textLim W et al. (2006) Meta-analysis: low-molecular-weight heparin and bleeding in patients with severe renal insufficiency. Ann Intern Med 144: 673–684

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Petersen JL et al. (2004) Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes: a systematic overview. JAMA 292: 89–96

    Article  CAS  Google Scholar 

  2. Eikelboom JW et al. (2005) Unfractionated and low-molecular-weight heparin as adjuncts to thrombolysis in aspirin-treated patients with ST-elevation acute myocardial infarction: a meta-analysis of the randomized trials. Circulation 112: 3855–3867

    Article  CAS  Google Scholar 

  3. Wallentin L et al. (2003) Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomized trial in acute myocardial infarction. Circulation 108: 135–142

    Article  CAS  Google Scholar 

  4. Antman EM et al. (2006) Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction. N Engl J Med 354: 1477–1488

    Article  CAS  Google Scholar 

  5. Collet JP et al. (2005) Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events. Eur Heart J 26: 2285–2293

    Article  Google Scholar 

  6. Hulot JS et al. (2005) Dosing strategy in patients with renal failure receiving enoxaparin for the treatment of non-ST-segment elevation acute coronary syndrome. Clin Pharmacol Ther 77: 542–552

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Pitié-Salpêtrière Hospital, Paris, France

    Jean-Philippe Collet & Gilles Montalescot

Authors
  1. Jean-Philippe Collet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gilles Montalescot
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean-Philippe Collet.

Ethics declarations

Competing interests

G Montalescot has received research grants, lecture fees and honoraria from Sanofi Aventis. J-P Collet declared he has no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Collet, JP., Montalescot, G. Does severe renal insufficiency increase the risk of bleeding after administration of low-molecular-weight heparin?. Nat Rev Nephrol 2, 616–617 (2006). https://doi.org/10.1038/ncpneph0323

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0323

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing